Tariq Siddiqui, MD
Cardiovascular Disease · El Paso, TXNPI 1487879300
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 35 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 38.8% of the total. Reporting peaked in 2019 at $27,548 and has fallen 87.2% since, to $3,525 in 2025. Among cardiovascular disease clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 443 payments — averaging $111.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$19K
- Medtronic$6K
- Regeneron Healthcare Solutions, Inc.$5K
- Surmodics, Inc.$2K
- Penumbra, Inc.$2K
- Abbott$2K
- plus $12K from 29 others
What the payments were for
- Consulting fees$130%
- Speaking & faculty fees$22,19045%
- Travel & lodging$8,67718%
- Food & beverage$18,29937%
- Education$910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 12 | $19,097 |
| Medtronic(2 entities) | 156 | $6,195 |
| Regeneron Healthcare Solutions, Inc. | 13 | $5,254 |
| Surmodics, Inc. | 29 | $2,457 |
| Penumbra, Inc. | 7 | $2,341 |
| Abbott | 36 | $2,282 |
| Inari Medical, Inc. | 14 | $2,084 |
| Boston Scientific | 60 | $1,924 |
| Philips North America LLC | 26 | $1,317 |
| Medical Device Business Services, Inc. | 3 | $944 |
| Abiomed | 10 | $909 |
| Edwards Lifesciences | 12 | $877 |
| Angiodynamics, Inc. | 5 | $708 |
| Cardiva Medical, Inc. | 11 | $641 |
| E.r. Squibb & Sons, L.L.C. | 11 | $273 |
| Terumo Medical Corporation | 2 | $259 |
| Regeneron | 3 | $247 |
| AstraZeneca | 2 | $243 |
| Biosense Webster, Inc. | 1 | $145 |
| Impulse Dynamics (USA) Inc. | 1 | $128 |
| Shockwave Medical, Inc | 2 | $124 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $113 |
| Thrombolex, Inc. | 1 | $93 |
| Argon Medical Devices, Inc. | 1 | $84 |
| Chiesi USA, Inc. | 1 | $84 |
| EKOS Corporation | 1 | $77 |
| Novartis | 4 | $67 |
| Asahi Intecc USA, Inc. | 1 | $66 |
| Endologix LLC | 2 | $55 |
| Pfizer | 4 | $52 |
| W. L. Gore & Associates, Inc. | 2 | $41 |
| Johnson & Johnson | 2 | $40 |
| Bracco Diagnostics Inc. | 1 | $16 |
| Revance Therapeutics, Inc. | 1 | $15 |
| Z-medica, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PRALUENT$23,952
- Sublime 014 Rx PTA Balloon Dilatation Catheter$2,779
- Indigo System$1,981
- Sublime Radial Access 018 RX PTA Dilatation Catheter$1,597
- FLOWTRIEVER CATHETER, S$1,582
- CT THROMBECTOMY SYSTEM KIT$1,582
- Micra$1,214
- Sublime Microcatheter, 014, 65cm, Straight$1,181
- Sublime Microcatheter, 014, 65cm, Angle$1,181
- Carto 3 System$944
- Impella$649
- AlphaVac$615
- AMPLATZER$587
- Sublime Radial Access Guide Sheath$416
- Pounce Thrombectomy$416
- Pounce Venous Thrombectomy System$416
- ENDURANT IIS$401
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$356
- OPTIMIZER$255
- FARXIGA$243
How this compares
$49,269 in reported general payments places this provider in the 90th percentile of 1,515 cardiovascular disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Furosemide | 14 | $46 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in El Paso
- David TurbayEl Paso$175K
- Venkatachalam MulukutlaEl Paso$157K
- Juan TaverasEl Paso$91K
- Ramin Farzaneh-FarDallas$17.1M
- John OsborneGrapevine$1.3M
- Darren McGuireDallas$1.2M
- Peter McCulloughDallas$664K
- Ann NavarDallas$616K
- Biykem BozkurtHouston$606K
- Milton PackerDallas$530K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.